14.59USD+2.39%Mkt Cap: 1.90B $P/E: —1d ago
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clin…
Industry Peers
Diagnostics & Researchvs Diagnostics & Research
P/B
Cheaper
1M Perf
Lower
$186.32BUSDP/E 27.6
$134.82BUSDP/E 36.8
$43.51BUSDP/E 42.0
$41.53BUSDP/E 38.7
$38.88BUSD
$37.53BUSDP/E 26.7
$36.82BUSDP/E 47.7
$32.25BUSDP/E 24.0
$26.60BUSDP/E 31.9
$25.82BUSDP/E 30.0
$23.46BUSDP/E 23.4
$22.96BUSDP/E 24.8
$19.89BUSD
$15.12BUSDP/E 33.3
$12.91BUSDP/E 26.9
$12.41BUSDP/E 53.5
$10.92BUSD
$8.81BUSDP/E 20.6
$6.41BUSD
$5.52BUSDP/E 222.2
$5.06BUSDP/E 43.3
$4.85BUSD
$4.69BUSDP/E 54.4
$3.65BUSDP/E 25.7
$3.43BUSD
$2.93BUSD
$2.04BUSD
$1.48BUSDP/E 37.4
$1.48BUSDP/E 22.4
$1.47BUSD
$1.40BUSD
$1.13BUSD
$1.01BUSDP/E 21.1
$723.37MUSD
$615.20MUSDP/E 40.1
$582.78MUSD
$539.30MUSD
$297.38MUSDP/E 3.0
$282.06MUSD
$233.52MUSD
$190.51MUSD
$147.80MUSD
$112.34MUSD
$94.30MUSDP/E 18.2
$77.88MUSD
$58.94MUSD
$44.26MUSD
$27.97MUSD
$27.15MUSD
$22.69MUSD
$17.60MUSD
$12.55MUSD
$10.07MUSDP/E 63.2
$9.85MUSD
$9.02MUSD
$8.78MUSD
$6.77MUSD
$6.29MUSD
$5.98MUSD
$5.10MUSD
$4.66MUSD
$3.81MUSD
$3.86MUSDP/E 2.8
$2.93MUSD
$2.79MUSD
$2.43MUSD
$1.29MUSD
$314.2KUSDP/E Infinity
$14.0KUSD
Indicators:|
Key Statistics
Company
Market Cap1.90B $
Enterprise Value2.16B $
Revenue (TTM)745.97M $
Gross Profit314.29M $
Net Income (TTM)-108.03M $
Revenue/Share5.803 USD
Last Price14.59 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees2.5K
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)40.02
PEG2.09
EV/EBITDA506.57
EV/Revenue2.90
P/S2.55
P/B2.28
EPS (TTM)-0.77
EPS (Forward)0.36
52W Range
4.72098% of range14.79
52W High14.79 USD
52W Low4.720 USD
Profitability
Gross Margin43.21%
Oper. Margin-9.34%
EBITDA Margin0.57%
Profit Margin-14.85%
ROE-12.91%
ROA-7.94%
Growth
Revenue Growth11.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF5.23M $
CapEx (TTM)27.01M $
FCF Margin4.45%
FCF Yield1.75%
Net Debt262.39M $
Net Debt/EBITDA61.49
Balance Sheet
Debt/Equity0.49
Current Ratio4.42
Quick Ratio3.71
Book Value/Sh6.392 USD
Cash/Share1.122 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.8 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)15.06 USD
Upside (mean)+3.2%
Target Range11.00 USD – 25.00 USD
$11.00+3.2% to mean$25.00
# Analysts9
Ownership
Shares Out.130.21M
Float118.22M
Insiders2.06%
Institutions108.38%
Short Interest
Short Ratio6.0d
Short % Float7.64%
Short % Out.6.49%
Shares Short8.45M
Short (prev mo.)8.62M
Technical
SMA 509.896 (+47.4%)
SMA 20010.15 (+43.8%)
Beta1.81
S&P 52W Chg20.05%
Avg Vol (30d)2.53M
Avg Vol (10d)5.31M
Technical Indicators
RSI (14)81.1
MACD1.1424
MACD Signal0.8250
MACD Hist.+0.3174
BB Upper14.52 USD
BB Middle11.71 USD
BB Lower8.907 USD
BB Width47.90%
ATR (14)0.6692 USD
Vol Ratio (20d)1.04x